• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
3-Bromo-4-fluorobenzaldehyde
5-Methyl-1,3,4-oxadiazol2(3H)-one
4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride
4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine
3-Pyridinecarboxaldehyde
Ethyl 3 Fluorobenzoate

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

expresspharmaJune 24, 2021

Tag: Dr Reddy’s , Icosapent Ethyl capsules , triglyceride

Dr Reddy’s Laboratories 21st launched Icosapent Ethyl capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US

The company has launched the capsules in one gram strength after approval by the US Food and Drug Administration (USFDA), the company said in a regulatory filing.

Dr Reddy’s Icosapent Ethyl is available in one gram capsules in a bottle count size of 120’s count. It is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Previous:Turkish COVID-19 vaccine starts phase-III trials

Next:Adroit Biomed develops orally-dissolving mini effervescent tablet to prevent, manage and recover from COVID-19

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Medium chain triglycerides Powder(palm oil)

Medium chain triglycerides Powder(palm oil)
Omega-3 Triglycerides

Omega-3 Triglycerides
Miglyol -812 (triglycerides of capric/caprylic acids)

Miglyol -812 (triglycerides of capric/caprylic acids)
Medium chain triglycerides Powder(Coconut oil)

Medium chain triglycerides Powder(Coconut oil)
Medium Chain Triglyceride

Medium Chain Triglyceride
Triglyceride

Triglyceride
Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides

Sinomega Omega-3 Refined Fish Oil EPA18/DHA12 Triglycerides
Conjugated Linoleic Acid-Triglyceride

Conjugated Linoleic Acid-Triglyceride
MCT Oil（Medium Chain Triglycerides）

MCT Oil（Medium Chain Triglycerides）
omega-3-acid triglycerides

omega-3-acid triglycerides

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service